Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures

被引:9
|
作者
Pedersen, Niels Lech [1 ]
Petersen, Mathias Mertz [1 ]
Ladd, Jon J. [2 ]
Lampe, Paul D. [2 ]
Bresalier, Robert S. [3 ]
Davis, Gerard J. [4 ]
Demuth, Christina [5 ]
Jensen, Sarah O. [5 ]
Andersen, Claus L. [5 ]
Ferm, Linnea [1 ]
Christensen, Ib J. [1 ]
Nielsen, Hans J. [1 ,6 ]
机构
[1] Hvidovre Univ Hosp, Dept Surg Gastroenterol, Hvidovre, Denmark
[2] Fred Hutchinson Canc Res Ctr, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA
[3] MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX USA
[4] Abbott Labs Inc, Canc Core R&D, Abbott Pk, IL USA
[5] Aarhus Univ Hosp, Dept Mol Med, Skejby, Denmark
[6] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
基金
美国国家卫生研究院;
关键词
Colorectal cancer; Biomarkers; Preanalytical variation; Bowel preparation; Centrifugation; AFP; CA19-9; CEA; hs-CRP; CyFra21-1; Ferritin; Galectin-3; TIMP-1; BAG4; IL6ST; vWF; CD44; EGFR; ligand; cfDNA; BIOLOGICAL VARIATION; BIOACTIVE SUBSTANCES; BOWEL PREPARATION; TUMOR-MARKERS; CANCER; RECOMMENDATIONS; COLONOSCOPY; TRIAGE; SERUM; PANEL;
D O I
10.1016/j.cca.2020.03.035
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Introduction: Blood-based, cancer-associated biomarkers are susceptible to a variety of well-known preanalytical factors. The influence of bowel preparation before a diagnostic colonoscopy on biomarker levels is, however, poorly investigated. The present study assessed the influence of bowel preparation on colorectal cancer-associated biomarkers. In addition, the effect of single versus double centrifugation of plasma biomarkers was assessed. Methods: Blood samples were collected pre- and post-bowel preparation from 125 subjects scheduled for first time diagnostic colonoscopy due to symptoms attributable to CRC. The samples were separated into serum and EDTA plasma, and analyzed by four independent collaborators for: 1) the proteins AFP, CA19-9, CEA, hs-CRP, CyFra21-1, Ferritin, Galectin-3 and TIMP-1, 2) the proteins BAG4, IL6ST, vWF, CD44 and EGFR, 3) the glycoprotein Galectin-3 ligand, and 4) cell-free DNA (cfDNA). Statistical analysis of biomarker data has been performed using mixed modelling, including repeated measures. Results: The biomarkers generally showed negligible variation between pre- and post-bowel preparation except for CyFra21-1, Ferritin, BAG4 and cfDNA. CyFra21-1 levels were systematically reduced with 29% (95% CI 21-36%) by bowel preparation (p <= 0.0001). Ferritin was not significantly different between pre- and post-bowel preparation (p = 0.07), however the estimated difference (increase) was 18%. BAG4 was systematically reduced by 12% (95% CI 1-22%, p = 0.04), while cfDNA showed a significant increase of 28% (95% CI 17-39%, p < 0.0001). Double centrifugation compared to single centrifugation showed reduced vWF (ratio 0.86, p <= 0.0001) and CD44 (ratio 0.85, p = 0.016), but increased IL6ST levels (ratio 1.18, p = 0.014). Conclusions: Results of the present study demonstrated systematic, statistically significant differences between pre-bowel and post-bowel preparation levels for three independent blood-based biomarkers (BAG4, CyFra21-1, cfDNA), illustrating the importance of timing of sample collection for biomarker analyses.
引用
收藏
页码:39 / 53
页数:15
相关论文
共 50 条
  • [31] EVALUATION OF NEW OCCULT BLOOD-TESTS FOR DETECTION OF COLORECTAL NEOPLASIA
    STJOHN, DJB
    YOUNG, GP
    ALEXEYEFF, MA
    DEACON, MC
    CUTHBERTSON, AM
    MACRAE, FA
    PENFOLD, JCB
    GASTROENTEROLOGY, 1993, 104 (06) : 1661 - 1668
  • [32] OSMR and SEPT9: promising biomarkers for detection of colorectal cancer based on blood-based tests
    Yuan, Peng
    Cheng, Xiaojing
    Wu, Xiaojiang
    Li, Lin
    Zhang, Lianhai
    Li, Ziyu
    Xing, Xiaofang
    Du, Hong
    Wang, Xiaohong
    Hu, Ying
    Zhang, Qingyun
    Deng, Guoren
    Wen, Xianzi
    Ji, Jiafu
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 131 - 139
  • [33] Comparison of three faecal occult blood tests in the detection of colorectal neoplasia
    Hope, RL
    Chu, G
    Hope, AH
    Newcombe, RG
    Gillespie, PE
    Williams, SJ
    GUT, 1996, 39 (05) : 722 - 725
  • [34] Blood-based cfDNA Test shows good Sensitivity for Early Detection of Colorectal Cancer
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2025, 150 (06) : 249 - 249
  • [35] Blood-based miRNA In Vitro Diagnostic Tests for Early Detection of Gastric and Other Cancers
    Zhou, Lihan
    Tang, Yewchung
    CANCER SCIENCE, 2023, 114 : 19 - 19
  • [36] The Development of a Blood-Based Gene Expression Test for the Early Detection of Breast Cancer
    Loenneborg, A.
    TUMOR BIOLOGY, 2008, 29 : 20 - 20
  • [37] Early detection of myocardial ischemia by a novel blood-based biomarker: The kinetics of ischemia modified albumin
    deFilippi, C
    Yoon, S
    Bounds, C
    Romar, L
    Ro, A
    Herzog, W
    Stafford, L
    Christenson, RH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 340A - 341A
  • [38] Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages
    Rogmans, Christoph
    Feuerborn, Julia
    Treeck, Leonie
    Tribian, Nils
    Floerkemeier, Inken
    Arnold, Norbert
    Weimer, Jorg Paul
    Maass, Nicolai
    Jansen, Peer
    Lieb, Wolfgang
    Dempfle, Astrid
    Bauerschlag, Dirk O.
    Hedemann, Nina
    CANCERS, 2022, 14 (23)
  • [39] Evaluation of Multigene Methylation for Blood-Based Detection of Colorectal Cancer
    Xu, Yingshuo
    Tan, Ailin
    Liang, Rui
    Qu, Huaidong
    Li, Xiankun
    Wang, Zhiqiang
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (10) : 402 - 409
  • [40] Colorectal cancer detection rates of blood-based assay published
    Brown, Emily
    COLORECTAL CANCER, 2014, 3 (03) : 246 - 246